20 participants
Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-10-23
- Start Date:
- 2022-03-01
- Completion:
- 2024-04-30
Conditions
- NSCLC
- EGFR Gene Mutation
Interventions
- OTHER
No Results Yet